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ABSTRACTSpalliation and long term survival respectively. Survival analysis was un-
dertaken with Kaplan-Meier analyses (Mantel-cox).
Results: 160 patients were identiﬁed (median age 74.5; male:female
1.8:1). Primary site colonic in 56, rectal in 104 and metastases in 102.
Overall median survival was 50 weeks. 71 patients had palliative chemo-
therapy. Palliative R2 resections were undertaken in 29 patients and 62
patients defunctioned. 69 patients had no surgical intervention. Absence of
metastasis did not confer a signiﬁcant survival beneﬁt (p¼0.1) while
chemotherapy signiﬁcantly improved survival (p¼0.001). Palliative
resection signiﬁcantly improved survival compared to defunctioning and
non-surgical management (p¼0.05); and conferred a signiﬁcant survival
beneﬁt compared to defunctioning alone (p¼0.036).
Conclusions: Chemotherapy signiﬁcantly improved survival. Distant
metastasis did not alter prognosis. In patients managed surgically, R2
resection conferred a signiﬁcant survival advantage and should be
considered in all palliative patients with advanced disease when
appropriate.0163: STAGE MIGRATION IN CURATIVE COLORECTAL CANCER
RESECTIONS
L.M. Quinn, A.A. Sheikh, S. Fields-Delaney, M.J. Tighe, B.A. Taylor.
Warrington and Halton Hospitals NHS Trust, Warrington, UK.
Introduction: The NHS Bowel Cancer Screening Programme introduced in
2006 aimed at detecting pre-malignant colorectal disease in patients aged
>60 years. We assessed its impact on Dukes Stage presentation in patients
undergoing curative colorectal resections.
Method: All patients undergoing curative resection between 2008 and
2012 were identiﬁed from a prospective database. Age at diagnosis and
histological Duke's Stage were analysed.
Results: 467 patients were identiﬁed (median age 69, male: female ratio
1.67:1). Total number of curative resections ranged from 111-123 (mean
117). Dukes A cancers signiﬁcantly decreased from 32.2% in 2008 to 15.5%
in 2012 (p¼0.0024 chi-square test). Dukes B cancers rose from 26.3% to
38% in the same time period (p¼0.05 Chi-square test). Dukes C cancers
increased by 4.9%, however this did not attain statistical signiﬁcance
(p¼0.516 chi-square test).
Conclusions: Following BCSP introduction, Dukes A cancers have
decreased with a rise in Dukes B and C cancers in our cohort. The total
number of annual curative resections remains unchanged. Stage
migration to more advanced disease in curative resections may be
attributable to more aggressive endoscopic treatment of premalignant
adenomatous and Dukes A disease. Evaluation of stage migration in
larger cohorts is needed, which may necessitate screening in younger
patients.0170: MEDICAL NEGLIGENCE CLAIMS AND COLORECTAL MALIGNANCY
IN THE NHS
Georgios Markides 1,2, Chris Newman 1,2. 1Huddersﬁeld Royal Inﬁrmary,
Huddersﬁeld, UK; 2Airedale General Hospital, Keighley, UK.
Background: NHS clinical negligence claims and associated compensa-
tions are constantly rising. Our aim was to identify the magnitude, trends
and causes of malpractice claims in relation to a common pathology such
as colorectal cancer (CRC) in the NHS.
Methods: Data submitted to the NHS Litigation Authority from April 2003
to April 2012 in relation to CRC was acquired. This was subsequently
reviewed, categorised clinically and analysed.
Results: 169 claims were identiﬁed, of which 123 (73%) cases had been
closed. 80 (65%) of these claims were successful. An increasing overall
claim frequency and success rate has been recorded over the last few
years. Total litigation expenses were £8.6 million out of which 39% were
paid out as legal expenses. The commonest cause of complaint in suc-
cessful claims was in relation to diagnostic delays or failures (58%, £5.1
million), with a delay or failure by the clinician to take action in response
to an abnormal investigation result being a major factor. The occurrence
of peri-operative complications (20%, £1.6 million) was the second com-
monest cause.
Conclusion: Average frequency and success rates of “CRC” related
malpractice claims in secondary care in the NHS are rising. Diagnostic
failures and/or delays are signiﬁcant contributing factors.0171: FLEXIBLE SIGMOIDOSCOPY ALONE FOR RIGHT SIDED COLON CAN-
CER WITH COLORECTAL SYMPTOMS
Kamran Khatri, Ladwa Nikhil, Baig M.K, McFall Malcolm,
Pauline Whitehouse. Western Sussex Hospitals NHS Trust, Worthing, UK.
Aims: The objective of this study is to identify all the right sided colon
cancers (including splenic ﬂexure), which may have been missed if ﬂexible
sigmoidoscopy alone is used as a sole investigation.
Methods: All right sided colon cancers from January 2010 to June 2012
were identiﬁed through a prospectively collected regional cancer database.
Results: One hundred and ninety patients were identiﬁed with mean age
of 63 (32 - 94) years. Thirty-three patients were admitted with bowel
obstruction (22) and through BCSP (11) and were excluded. One hundred
and twenty-eight patients underwent right colonic resection. Of the
remaining 158 patients, 147 patients presented with either IDA or
abdominal mass or both. Eleven patients were diagnosed with right sided
colon cancer presenting with symptoms of altered bowel habits, rectal
bleeding or/and abdominal pain without IDA or abdominal mass.
Conclusion: Approximately 7 % (11/158) colonic cancer would have been
missed over 30 months, if these patients had undergone ﬂexible
sigmoidoscopy alone. Patients undergoing ﬂexible sigmoidoscopy alone to
investigate lower GI symptoms should be informed regarding this possible
miss rate.0172: THE VALUE OF ANORECTAL INVESTIGATIONS IN PREDICTING PA-
TIENT OUTCOME AFTER BIOFEEDBACK TREATMENT FOR MANAGEMENT
OF FAECAL INCONTINENCE
Michael Feretis, Sharad Karandikar, Amanda Carter, Mark Chapman. Heart
of England NHS Foundation Trust, Birmingham, West Midlands, UK.
Aim: Identify predictors of patient outcome after a course of biofeedback
for management of Faecal Incontinence (FI).
Methods: Retrospective analysis of prospectively collected data was per-
formed on 137 consecutive patients that underwent biofeedback between
January 2007 - June 2012. Data was collected on patient demographics,
baseline incontinence scores, anorectal manometry, rectal sensitivity
studies and endoanal ultrasound reports. After performing univariate
analysis data was entered in a logistic regression analysis model in order to
identify independent predictors of the outcome.
Results: 137 patients (123 female) with a median Wexner score 12 (range
5-20) prior to biofeedback were identiﬁed. 95/137 (69%) responded
favourably to biofeedback (‘responders'). Univariate analysis showed that
the following variables differed signiﬁcantly (p<0.05) between ‘re-
sponders' and ‘non-responders': age, duration of symptoms, severity of FI,
mean maximum squeeze and resting anal pressure. However, after
entering the data in a logistic regression model, age, duration and severity
of incontinence were the only independent predictors of patients'
response to biofeedback.
Conclusion: Younger age, shorter duration of symptoms and lower FI
scores were independent predictors of favourable patient outcome
after biofeedback. These variables could therefore be used to aid
patient selection. Anorectal manometry /electrophysiology have
limited value in identifying patients that would beneﬁt from
biofeedback.0198: SURGICAL SEPSIS AND DELAYS IN SOCIAL SERVICES AND INTER-
VENTION SERVICES ACCOUNT FOR PROLONGED HOSPITAL LENGTH OF
STAY IN GENERAL AND COLORECTAL SURGERY
Carl Kotze. Eastbourne District General Hospital, Eastbourne, UK.
Background: Current economical climate challenges have enforced ser-
vice reconﬁguration, which is now being implemented across the NHS.
Cost saving methods are being sought in order to overcome a £20 billion
deﬁcit. Addressing factors which inﬂuence length of hospital stay (LOS) in
the surgical patient journey may save costs.
Methods: General and colorectal surgical patients admitted within a 30d
period to Eastbourne DGH for emergency and elective procedures were
audited. Corrected LOS was determined by subtracting absolute LOS from
an average expected LOS for procedure type. Causes for increased LOS
were identiﬁed. Annual cost for prolonged LOS was calculated. Mann-
Whitney test was used to assess signiﬁcant differences in age between
factors.
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ABSTRACTSResults: 16 of 183 (8.7%) patients had increased LOS. Mean age was 74 y
(SD+-15y). Total LOS for the cohort was 366d (mean LOS 22d, SD+-20d) and
corrected LOS was 245d (mean 15.4d, SD+-18.8d). Surgical Sepsis
accounted for 143d, social service delays for 83d and intervention services
delays for 18d. There was no signiﬁcant difference for age between factors.
Overall estimated annual extra bed cost was£661500.
Conclusion: Incidence of surgical sepsis and the efﬁciency of intervention
services and social services should be targeted to reduce prolonged sur-
gical LOS.
0201: OUTPATIENT FLUID AND ELECTROLYTE MANAGEMENT FOR PA-
TIENTS WITH HIGH OUTPUT STOMAS AND ENTEROCUTANEOUS
FISTULAE
N.D. Appleton, A. Corris, C. Edwards, A. Kenyon, C.J. Walsh. Wirral
University Teaching Hospital NHS Foundation Trust, Wirral, UK.
Aim: Fluid and electrolyte management for patients with high output
stomas/enterocutaneous ﬁstulae is challenging. Historically, their care
required repeated admissions to avoid ongoing complications eg, acute
renal failure. We report our experience of outpatient management of such
patients led by a nutrition support team.
Method: A retrospective analysis of a prospectively maintained data-
base was performed. All patients met their nutrition needs enterally.
Patients attend a ward based clinic with facilities for monitoring
(weight, ﬂuid balance, diet, PICC line care, bloods, urinary sodium and
medication review) and IV hydration and/or magnesium/potassium
supplementation. Individual cases are discussed at a weekly nutrition
support meeting.
Results: Between September 2009 - September 2012, 83 patients attended
(male:female 43:40, median age 66, range 18-92). 73 had high output
stomas, 11 had enterocutaneous ﬁstulas. Total clinic days attended was
1239 (median 9 range 1-109 days). On 224 visits, IV ﬂuids were adminis-
tered, of which 95 were given IV magnesium and three, IV potassium.
Eleven required admission (admission rate of 1%). Other outcomes were
either optimisation for surgery, discharge without surgery or long term
monitoring without inpatient stay.
Conclusion: Patients with complex ﬂuid balance and electrolyte needs can
be managed successfully in the outpatient setting.
0236: IS LAPAROSCOPIC SURGERY FOR RIGHT HEMICOLECTOMY COST-
EFFECTIVE?
Sarah Daniels, Arin Saha, Victoria Proctor, Khalid Habib. Doncaster Royal
Inﬁrmary, Doncaster, South Yorkshire, UK.
Aim: To compare oncological outcomes and cost of laparoscopic and open
surgery for right hemicolectomy.
Methods: Patients who had a right hemicolectomy from January to
November 2011 were identiﬁed from a prospectively maintained database
of operations. Oncological outcomes were recorded and costs of surgery
were calculated by costing each item of equipment used for each case.
Results: There were 44 patients (28 men (64%); median age 72.8 years
(range, 18.4-89.2)). Thirty-two patients (73%) had elective surgery. Thirty
patients (68%) had a laparoscopic operation (3 converted). Of the 17 open
cases, 8 (47%) were acute cases as compared to 4 emergency cases out of 27
laparoscopic cases (15%, P¼0.019). Primary pathology was cancer in 37 pa-
tients (84%). There were no differences between laparoscopic and open
surgery in surgical time (181 minutes vs. 134 minutes [open], P¼0.593),
resected nodes (18 vs. 16, P¼0.968), distance to nearest longitudinal margin
(65 cms vs. 75 cms, P¼0.078) or inpatient stay (7 vs. 8, P¼0.681). Laparo-
scopic surgery was signiﬁcantly more expensive (£1014 vs. £439, P¼0.032).
Conclusions: Laparoscopic surgery for right hemicolectomy is associated
with equivalent oncological adequacy but is considerably more expensive
than open surgery. This may be important in healthcare planning with
future ﬁnancial constraints.
0238: “ASSESSMENT OF ACCURACY IN PREDICTING SITE OF COLO-
RECTAL CANCER AT ENDOSCOPY”
James Davies, Sarah Mills. Wansbeck General Hospital, Ashington,
Northumberlan, UK.
Aim: Colorectal cancer is the third most common cancer in the UK with
endoscopy playing an important role in the bowel screening programme.
Site of cancer will determine type of surgery and any further investigation.This audit was undertaken to assess our accuracy in predicting site of
cancer.
Method: A central database was used to identify cases. Speciﬁc site of
cancer was compared against documented site at endoscopy, using a
standard of90% accuracy, as proposed by JAG (Joint Advisory Group on GI
Endoscopy).
Results: 357 cases were identiﬁed from 2011/12, and 315 included. 233
tumours (74%) were accurately sited. Most sited incorrectly were of little
signiﬁcance, however within the rectal cancer group (n¼108), 7 were
deemed recto-sigmoid and 8 sigmoid. Only 67% of rectal tumours had
distance from anal margin documented.
Conclusion: Accuracy was below standard which in part may be due to
poor documentation. There is confusion, particularly around rectal tu-
mours, but this group is of high importance as mistakes could delay
imaging (MRI) and treatment. This highlights a potential pothole and it
is vital that endoscopists have an understanding of anatomy and its
surgical relevance. We will address our ﬁndings at re-audit.0252: THE USE OF ORAL IRON SUPPLEMENTATION AT DISCHARGE
FOLLOWING COLORECTAL CANCER RESECTION - WE COULD DO BETTER
Debashis Dass, Thomas J. Edwards, Ian Eyre-Brooks, Louise E. Hunt,
Paul M. Mackey, Christopher J. Vickery, Catherine J. Walter. Musgrove
Park Hospital Foundation Trust, Taunton, Somerset, UK.
Aims: Iron-deﬁciency is common following colorectal cancer (CRC) resec-
tion. For those who require adjuvant chemotherapy, pre-existing anaemia
increases the risk of requiring blood transfusion. We aimed to assess current
provisions of post-operative oral iron supplementation (Fe++).
Methods: In 2011, we undertook a single-centre retrospective study of
patients undergoing potentially-curative CRC resections. Demographic,
haematological, histological and therapeutic data was retrieved. Follow-up
haematological data was obtained for a cohort of patients who re-attended
for adjuvant chemotherapy.
Results: 118 patients were identiﬁed, 61 patients were anaemic on
admission and 83 on discharge, of whom 46 had Hb<10g/dL. Seven (8%) of
the anaemic patients had Fe++ prescribed at discharge. 32 patients received
adjuvant chemotherapy, of these 24 (75%) were anaemic at discharge of
whom 16 (67%) remained anaemic at the start of chemotherapy. The mean
haemoglobin rise between discharge and commencing chemotherapy was
2.1g/dL (SD 0.57) with Fe++ versus 1.6g/dL (SD 1.33) without. Three pa-
tients, all with untreated anaemia required blood transfusion during
chemotherapy.
Conclusions: A majority of patients are anaemic following resectional
surgery for CRC. Treatment at discharge was inadequate at the study
centre. Fe++ may improve restoration of normal haemoglobin prior to
adjuvant chemotherapy with the potential to reduce transfusion
requirement.0387: ASIT-DUKES' CLUB/ACPGBI PRIZE WINNER: CT VIRTUAL COLO-
NOSCOPY (CTVC) AND THE USE OF IV HYOSCINE BUTYLBROMIDE
A.B. Scrimshire, L.J. Steinberg. NHS, North West, UK.
Aims: To assess the effect of IV Hyoscine butylbromide (Buscopan) on
luminal distension for CT virtual colonoscopy (CTVC).
Methods:Over 4months patients were randomly selected and given 20mg
of Buscopan intravenously before undergoing CTVC. These scans were
compared to a set of randomly selected control scans where Buscopan had
not been administered.
Using the same grading system as Taylor et al, a GI radiology consultant
graded all of the images. The colon was divided into 6 segments (Caecum,
Ascending, Transverse, Descending, Sigmoid, Rectum) and each was
graded from 0 (collapsed colon) to 3 (excellent distension, folds <2mm) in
supine and prone positions.
Results: There were 46 patients in total (23 per group). The Buscopan
group showed improved distension in all segments of colon. There was a
50% increase in the number of 3’s scored in the ascending and descending
colon images, 30% for transverse and 20% for rectum and sigmoid. Caecal
imaging had a high rate of 3 scores in both groups. Overall 86% of Buscopan
images scored 3 compared to 54% of non-Buscopan.
Conclusions: The use of IV Buscopan improves colonic distension for CTVC
providing better imaging. This may help avoid repeat investigations.
